drugset / Trial / NCT05746351

Analgesic Additives to Epidural Bupivacaine in Normal Labor

NCT05746351

Unknown 69 enrolled Assiut University
RandomizedParallel-groupOpen-labelSupportive care

Summary

The aim of the study will be to compare the role of Dexmedetomidine, Nalbuphine and fentanyl as additives to epidural bupivacaine in painless vaginal delivery as regard of effectiveness analgesia and maternal safety.

Timeline

Start
2023-03
Primary completion
2025-03
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/ml Other
Comparator Fentanyl Other / unclassified 2 ug/ml Other
Comparator Nalbuphine Small molecule 0.2 mg/ml Other

Indications

No indication recorded.